Eileen Carry, PhD

Graduate Student
Department of Medicinal Chemistry

Eileen Carry graduated with her PhD from the Department of Medicinal Chemistry at Rutgers University in 2021. Her research efforts focused on investigation of dihydromyricetin as a lead molecule towards the development of a druglike derivative with potential to treat alcohol use disorder.

After graduating, Dr. Carry is the founder and Chief Scientific Officer of Zena Therapeutics.